An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

计划入组 77 人 · 首次发布于 2010 年 12 月 8 日

Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery

计划入组 42 人 · 首次发布于 2009 年 5 月 18 日

Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery

计划入组 75 人 · 首次发布于 2008 年 3 月 5 日

QAP14

p38 MAPK and MAPKAP-K2 inhibitors(Boehringer Ingelheim)

MAP2K4 inhibitors (cancer)

ARDS Clinical Pipeline Expands with 50+ Companies Developing Novel Therapies

Urinary MMP-1 Identified as Potential Biomarker for Calcium Oxalate Kidney Stone Disease

Longeveron's Lomecel-B Shows Promise in Mild Alzheimer's Disease by Targeting MMP14